Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (TOCA) and Tocagen Inc (TOCA)


There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sarepta Therapeutics (NASDAQ: SRPT) and Tocagen Inc (NASDAQ: TOCA) with bullish sentiments.

Sarepta Therapeutics (NASDAQ: SRPT)

In a report released today, Debjit Chattopadhyay from H.C. Wainwright maintained a Buy rating on Sarepta Therapeutics (NASDAQ: SRPT), with a price target of $96. The company’s shares closed on Friday at $97.61, close to its 52-week high of $100.30.

According to TipRanks.com, Chattopadhyay is a 3-star analyst with an average return of 2.0% and a 45.9% success rate. Chattopadhyay covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Mersana Therapeutics Inc, and Voyager Therapeutics Inc.

Currently, the analyst consensus on Sarepta Therapeutics is Strong Buy and the average price target is $102.27, representing a 4.8% upside.

In a report issued on June 1, Robert W. Baird also maintained a Buy rating on the stock with a $101 price target.

See today’s analyst top recommended stocks >>

Tocagen Inc (NASDAQ: TOCA)

In a report released today, Swayampakula Ramakanth from H.C. Wainwright initiated coverage with a Buy rating on Tocagen Inc (NASDAQ: TOCA) and a price target of $14.50. The company’s shares closed on Friday at $9.64, close to its 52-week low of $8.60.

According to TipRanks.com, Ramakanth is a 4-star analyst with an average return of 9.4% and a 44.4% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as Diffusion Pharmaceuticals Inc, IntelGenx Technologies, and Trillium Therapeutics.

Tocagen Inc has an analyst consensus of Moderate Buy, with a price target consensus of $15.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts